-
EP1292617
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1292617
| EP1292617 - NOVEL COMPOUNDS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.12.2006 Database last updated on 18.01.2025 | Most recent event Tooltip | 08.12.2006 | Application deemed to be withdrawn | published on 10.01.2007 [2007/02] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza Philadelphia, PA 19103 / US | For all designated states SMITHKLINE BEECHAM PLC One New Horizons Court, Great West Road Brentford Middlesex TW8 9EP / GB | For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | [N/P] |
| Former [2003/12] | For all designated states SmithKline Beecham Corporation One Franklin Plaza Philadelphia, PA 19103 / US | ||
| For all designated states Smithkline Beecham PLC One New Horizons Court, Great West Road Brentford, Middlesex TW8 9EP / GB | |||
| For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB | Inventor(s) | 01 /
AGARWAL, Pankaj 251 West DeKalb Pike King of Prussia, PA 19406 / US | 02 /
COGSWELL, John, P. Five Moore Drive Research Triangle Park, NC 27709 / US | 03 /
KABNIC, Karen, S. 4138 Presidnetial Drive Lafayette Hill, PA 19444 / US | 04 /
LAI, Ying-Ta 516 Spruce Avenue Upper Darby, PA 19082 / US | 05 /
MARTENSEN, Shelby, A. Five Moore Drive Research Triangle Park, NC 27709 / US | 06 /
MURDOCK, Paul, R. New Frontiers Science Park South, Third Avenue Harlow, Essex CM19 5AW / GB | 07 /
SMITH, Randall, F. 4138 Presidential Drive Lafayette Hill, PA 19444 / US | 08 /
STRUM, Jay, C. Five Moore Drive Research Triangle Park, NC 27709 / US | 09 /
XIANG, Zhaoying 2413 Ridgeway Fort Lee, NJ 07024 / US | 10 /
XIE, Qing 310 Sawmill Lane Horsham, PA 19044 / US | 11 /
RIZNI, Safia, K. 4617 Pine Street Philadelphia, PA 19143 / US | [2003/12] | Representative(s) | Giddings, Peter John GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2003/12] | Giddings, Peter John, Dr. GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 01946653.1 | 22.06.2001 | [2003/12] | WO2001US19929 | Priority number, date | US20000213161P | 22.06.2000 Original published format: US 213161 P | US20000213156P | 22.06.2000 Original published format: US 213156 P | [2003/12] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0198342 | Date: | 27.12.2001 | Language: | EN | [2001/52] | Type: | A1 Application with search report | No.: | EP1292617 | Date: | 19.03.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2001 takes the place of the publication of the European patent application. | [2003/12] | Search report(s) | International search report - published on: | US | 27.12.2001 | (Supplementary) European search report - dispatched on: | EP | 18.02.2005 | Classification | IPC: | C07K14/47, C12N5/10, C12N5/16, C12N15/12, C12N15/63, C12N15/64 | [2003/12] | CPC: |
C07K14/47 (EP,KR)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/12] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | 08.01.2003 | Title | German: | Neuartige Verbindungen | [2003/12] | English: | NOVEL COMPOUNDS | [2003/12] | French: | COMPOSES | [2003/12] | Entry into regional phase | 08.01.2003 | National basic fee paid | 08.01.2003 | Search fee paid | 08.01.2003 | Designation fee(s) paid | 08.01.2003 | Examination fee paid | Examination procedure | 20.12.2001 | Request for preliminary examination filed International Preliminary Examining Authority: US | 08.01.2003 | Examination requested [2003/12] | 13.03.2006 | Despatch of a communication from the examining division (Time limit: M04) | 14.07.2006 | Application deemed to be withdrawn, date of legal effect [2007/02] | 25.08.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/02] | Fees paid | Renewal fee | 04.06.2003 | Renewal fee patent year 03 | 04.06.2004 | Renewal fee patent year 04 | 06.06.2005 | Renewal fee patent year 05 | 27.03.2006 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP0607054 (HONJO TASUKU [JP], et al) [X] 1-7 * the whole document *; | [X]US5536637 (JACOBS KENNETH [US]) [X] 1-7 * the whole document *; | [X]US5707829 (JACOBS KENNETH [US], et al) [X] 1-7 * the whole document *; | [PA]WO0125409 (MILLENIUM PHARMACEUTICALS INC [US]) [PA] 1-7 * Seq ID 3 is 91% identical with Seq ID 23 in 471 aa overlap (1:461:1-467) Seq ID 2 99.7% id in 935 nt overlap (1-932:125-1059);; figure 1; claim 9; sequence 3 *; | [E]WO0181363 (SMITHKLINE BEECHAM CORP [US], et al) [E] 1-7 * Human polynucleotide #29 is 78% identical with Seq ID 1in 1411 nt overlap;; sequence 29 *; | [A] - GILLER T ET AL, "TWO NOVEL HUMAN PANCREATIC LIPASE RELATED PROTEINS HPLRP1 AND HPLRP2 DIFFERENCES IN COLIPASE DEPENDENCE AND IN LIPASE ACTIVITY", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (19920815), vol. 267, no. 23, ISSN 0021-9258, pages 16509 - 16516, XP002251906 [A] 1-7 * hPLRP1 and hPLRP2 are each 46% identical with Seq ID 23;; figure 1 * | International search | [A]WO9205256 (GENETICS INST [US], et al) |